If you're looking for a blend of portable and powerful, then the Toshiba Portégé R830-1DZ could be right up your street.
It boasts an Intel Core i7-2640M dual-core processor running at 2.8GHz. Coupled with 8GB of RAM – and crucially, an SSD for storage – this laptop stormed through our WorldBench 6 benchmarking suite with a score of 153.
All of this speed is crammed into a dimunitive frame weighing under 1.5kg, making the Toshiba Portégé R830-1DZ a very good option for those who need to take a notebook with them wherever they go.
But its mobility credentials don't end there, as its battery lasted 453 minutes - that's seven-and-a-half hours - in the MobileMark 2007 tests. Again, that’s the best performance of the bunch.
The keyboard is very good to use, despite being small - it doesn't feel as though any of the keys have been made too small to use and it lends itself well to accurate typing.
The design is smart and sober, although it doesn't have the build or class of the MacBook Pro. Our sample’s solid-state storage means everything seems to feel run faster, and the drive itself is more robust. It stands a better chance of brushing off the shakes and rattles of everyday use.
You might think that the lack of spinning disk might make it quieter than the competition. But you'd be wrong. There's a surprisingly noisy fan in the Toshiba, and though it does a good job of keeping the Portégé cool – we found it comfortable to use on our lap for extended periods -– it is a great deal louder than other laptops of this size.
The screen is matt and non-reflective, driven by Intel’s integrated graphics processor. Connectivity – both wireless and wired -– is good, with a range of ports and standards at your disposal so you can hook up to the vast majority of peripherals and networks with no bother.
There's also an optical drive can read and write CDs and DVDs, which is not always a given on laptops of this size.















Comments
Toshiba R930 user said: Toshiba R830 and R930 and Z serie has problem with noisy fan Thee is no cure for now